“Economic Consequences of Administering Obinutuzumab As a Short Duration Infusion in Italian Patients With Advanced Follicular Lymphoma: A Cost Analysis”. 2022. Farmeconomia. Health Economics and Therapeutic Pathways 23 (1). https://doi.org/10.7175/fe.v23i1.1532.